The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending nivolumab-relatlimab (Opdualag) for people aged 12 or older with untreated advanced melanoma, making nearly 1300 patients eligible for the treatment.1
The combination of two monoclonal antibodies is given …
In an infamous YouTube video, Chad Michael Murray told One Tree Hill fans, "They're not…
0 0 1001 Parkway Residences in Filinvest City, Alabang, a high-rise residential condominium complex developed…
Australian authorities discovered the remains of a 12-year-old girl Thursday after she was reportedly snatched…
“Well, we’re all in the mood for a melody,” Billy Joel crooned in “Piano Man,”…
Parenting today feels like a wild ride, filled with thrilling surprises and unexpected twists. The…
Sign up for the View from Westminster email for expert analysis straight to your inboxGet…
This website uses cookies.